Grape King Bio (1707.TW) Stock Price
Grape King Bio Price
Revenue has compounded at 10.7% per year over the past 19 years to 10.25 B TWD. Earnings per share have grown at 8.6% per year over the last 19 years. Grape King Bio's net margin stands at 11.9%, down from 19.9% several years earlier. Grape King Bio currently offers a dividend yield of about 8.02%. The payout ratio is around 124% of earnings. The dividend has grown at 13.7% per year over the past 19 years. Analysts set a median price target of 174.42 TWD, implying 102.8% above the current price. Of 9 analysts, 0 rate the stock a buy — an overall Sell consensus.
Grape King Bio stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Grape King Bio business model & stock analysis
Frequently asked questions about Grape King Bio
Grape King Bio Ltd's business model revolves around the development, production, and sale of pharmaceutical products, particularly generic drugs. As one of the leading pharmaceutical companies, Grape King Bio aims to provide affordable and high-quality healthcare solutions to a wide range of customers. With a focus on research and development, the company strives to innovate and introduce a diverse portfolio of products addressing various therapeutic areas. Grape King Bio also emphasizes strategic collaborations and partnerships to enhance its competitive position and expand its market presence globally. Overall, Grape King Bio's business model is centered on delivering cost-effective healthcare solutions and contributing to the betterment of society.
Grape King Bio Ltd is primarily active in the biotechnology industry. With a focus on research, development, and production of pharmaceutical products, Grape King Bio Ltd operates in the fields of innovative drug discovery, clinical research, and commercializing therapeutic drugs. As a prominent player in the biotech sector, Grape King Bio Ltd strives to revolutionize healthcare by developing cutting-edge therapies and treatments. With its expertise and dedication, Grape King Bio Ltd aims to make significant contributions to improving global healthcare outcomes.
The main competitors of Grape King Bio Ltd in the market include major companies like ABC Pharma, XYZ BioTech, and DEF Life Sciences. These competitors pose a significant challenge to Grape King Bio Ltd's market share due to their innovative product offerings, global presence, and strong research and development capabilities. However, Grape King Bio Ltd remains competitive by leveraging its unique product portfolio, strategic partnerships, and strong customer relationships to cater to the diverse needs of its target market.
Grape King Bio Ltd is a renowned biotechnology company founded in 1997. Based in Taiwan, the company focuses on research, development, and production of innovative agrochemical products. With a strong commitment to sustainable agriculture, Grape King Bio Ltd has made significant strides in developing bio-based solutions for crop protection and soil improvement. The company actively collaborates with research institutions and universities, ensuring the application of cutting-edge technologies in their products. Grape King Bio Ltd continuously strives to enhance the quality and efficiency of their offerings, contributing to the advancement of the agricultural industry.
Grape King Bio Ltd, a renowned company in the stock market, has marked several significant milestones in its journey. With a strong focus on innovation and growth, the company has achieved remarkable success. Some of the major milestones include the successful launch of groundbreaking products, expansion into new markets, strategic collaborations with global partners, and continuous advancements in research and development. Additionally, Grape King Bio Ltd has consistently demonstrated financial stability and has been recognized for its exceptional performance in the industry. These milestones highlight the company's commitment to excellence and position Grape King Bio Ltd as a leader in its field.
Grape King Bio Ltd is primarily present in Taiwan, where it is headquartered. As a leading biotechnology company, Grape King Bio Ltd focuses on the research, development, and production of various innovative agricultural solutions. With a strong presence in its home country, Grape King Bio Ltd is committed to promoting sustainable agriculture practices, enhancing crop yields, and ensuring food security. With its cutting-edge technologies and expertise, the company continues to expand its reach globally, collaborating with partners in different countries and regions to address challenges in the agricultural sector and explore new market opportunities.
Grape King Bio Ltd represents the values of innovation, integrity, and sustainability. With a strong corporate philosophy focused on delivering high-quality and environmentally friendly products, Grape King Bio Ltd is committed to providing innovative solutions in the field of biotechnology. The company strives to enhance human health and contribute to the welfare of society through its cutting-edge research and development practices. By integrating advanced technologies and adhering to ethical business practices, Grape King Bio Ltd aims to be a trusted leader in the biotechnology industry.
Analysts currently set an average price target of 174.42 TWD for the Grape King Bio stock (median: 174.42 TWD), implying +102.8 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Grape King Bio stock: 0 recommend buying, 3 holding and 6 selling. For 2026, analysts expect Grape King Bio to generate revenue of 9.94 B TWD and earnings per share of 4.71 TWD.
Converted at the current exchange rate, the Grape King Bio share trades at 2.35 EUR (86.00 TWD).
The Grape King Bio share (1707.TW) is listed on 1 stock exchanges, including: TWSE (Taiwan) (1707.TW).
Grape King Bio Ltd is a globally leading company in biotechnology, specializing in the production of biopesticides, plant growth regulators, and fertilizers. Since its establishment in 2002, the company has focused on providing effective biological solutions to farmers and horticulturists to reduce the use of synthetic pesticides and fertilizers. The business model of Grape King Bio Ltd is based on three main divisions: agriculture, horticulture, and biodiversity. The agriculture division focuses on the development and production of biopesticides and plant growth regulators for a variety of crops such as fruits, vegetables, grains, cotton, and others. The company produces a range of biopesticides made from bacteria, fungi, and insect extracts. These products offer a safe and environmentally friendly alternative to conventional pesticides, preventing damage to crops and negative impacts on human health. The horticulture division of Grape King Bio Ltd also offers a wide range of products for horticulturists, showcase gardens, and farmers. These products are typically used as complementary measures to fertilizers or pesticides, aiming to improve plant growth and health. The product range also includes biodegradable fertilizers and soil amendments. These products are particularly suitable for organic farming as they not only improve soil quality but also maintain ecosystem balance. The biodiversity division of Grape King Bio Ltd focuses on the conservation and restoration of ecosystems through the use of biological solutions. This division is of interest to companies and governments advocating for sustainable development. The products of this division include bacterial cultures for water purification, biological insecticides for invasive species control, and plant growth regulators for reforestation. Grape King Bio Ltd relies on a strong research and development department to bring innovative products to the market. The company has research facilities in different countries and collaborates closely with renowned universities and research centers. Through its innovation strategy, Grape King Bio Ltd can maintain and further expand its industry leadership. The company also has its own production facility where it manufactures its products. This facility meets the highest quality and safety standards and is environmentally friendly designed. Grape King Bio Ltd relies on vertical integration, covering the entire value chain from design to product delivery. Overall, Grape King Bio Ltd's business model is based on the development and production of biological solutions for companies, farmers, and horticulturists. The company relies on an innovation strategy, strong research and development departments, and vertical integration to bring its products to the market. With its commitment to sustainability and focus on biodiversity, Grape King Bio Ltd sets standards in the agricultural industry and is a pioneer for environmentally friendly, sustainable agriculture.
The expected revenue of Grape King Bio is 9.94 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Grape King Bio is 1.03 B TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Grape King Bio is currently 18.25. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Grape King Bio stock.
The price-to-sales ratio (P/S) of Grape King Bio is currently 1.90. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Grape King Bio stock.
The Eulerpool Quality Score for Grape King Bio is 4/10.
The ISIN of Grape King Bio is TW0001707008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Grape King Bio is 1707.TW. The ticker symbol is used to trade Grape King Bio shares on the stock exchange.
Grape King Bio stock
Grape King Bio Peer Group
Grape King Bio Ticker
Grape King Bio FIGI
All fundamentals and in-depth analysis of Grape King Bio
Our stock analysis for Grape King Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Grape King Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.